GSK’s Arexvy Is A Vaccine Approved To Protect Older Adults From Respiratory Syncytial Virus (RSV) Disease In Malaysia
GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy (MAL24086007ARZ) has been approved in Malaysia for RSV, a common respiratory virus that can lead to serious negative clinical outcomes, such…